Safety Update On Certolizumab Pegol in Patients with Active Rheumatoid Arthritis with Long Term Exposure

被引：0
|
作者：
Mariette, Xavier [1 ]
van Vollenhoven, Rf. [2 ]
Bykerk, Vivian P. [3 ]
de Longueville, Marc [4 ]
Arendt, Catherine [4 ]
Luijtens, Kristel [5 ]
Cush, John J. [6 ]
机构：
[1] Univ Paris 11, Le Kremlin Bicetre, France
[2] Karolinska Inst, Stockholm, Sweden
[3] Hosp Special Surg, New York, NY 10021 USA
[4] UCB Pharma, Brussels, Belgium
[5] UCB, Brussels, Belgium
[6] Baylor Res Inst, Dallas, TX USA
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
503
引用
收藏
页码：S221 / S221
页数：1
相关论文
共 50 条
  • [41] DECLINE IN HEALTHCARE RESOURCE CONSUMPTION FOR PATIENTS WITH RHEUMATOID ARTHRITIS STARTING CERTOLIZUMAB PEGOL
    Saraux, A.
    Flipo, R.
    Fagnani, F.
    Cukierman, G.
    Joubert, J.
    Schuller, J.
    Massol, J.
    Combe, B.
    [J]. VALUE IN HEALTH, 2018, 21 : S301 - S301
  • [42] Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data
    Bykerk, Vivian P. P.
    Nash, Peter
    Nicholls, David
    Tanaka, Yoshiya
    Winthrop, Kevin
    Popova, Christina
    Tilt, Nicola
    Haaland, Derek
    [J]. RHEUMATOLOGY AND THERAPY, 2023, 10 (03) : 693 - 706
  • [43] Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data
    Vivian P. Bykerk
    Peter Nash
    David Nicholls
    Yoshiya Tanaka
    Kevin Winthrop
    Christina Popova
    Nicola Tilt
    Derek Haaland
    [J]. Rheumatology and Therapy, 2023, 10 : 693 - 706
  • [44] Exposure-response modeling of the ACR20 score in rheumatoid arthritis patients treated with certolizumab pegol
    Lacroix, B.
    Lovern, M.
    Stockis, A.
    Sargentini-Maier, M. L.
    Karisson, M. O.
    Friberg, L. E.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (09): : 1107 - 1107
  • [45] Effect of Certolizumab Pegol With Methotrexate on Home and Work Place Productivity and Social Activities in Patients With Active Rheumatoid Arthritis
    Kavanaugh, Arthur
    Smolen, Josef S.
    Emery, Paul
    Purcaru, Oana
    Keystone, Edward
    Richard, Lance
    Strand, Vibeke
    van Vollenhoven, Ronald F.
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (11): : 1592 - 1600
  • [46] BUDGET IMPACT ANALYSIS OF CERTOLIZUMAB PEGOL IN THE MANAGEMENT OF PATIENTS WITH MODERATE-TO-SEVERE ACTIVE RHEUMATOID ARTHRITIS IN GREECE
    Tzanetakos, C.
    Maniadakis, N.
    Kourlaba, G.
    Tzioufas, A.
    Goules, A.
    Theodoratou, T.
    Christou, P.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : 375 - 375
  • [47] Early Response As a Predictor of Long-Term Remission in DMARD-Naive Patients with Severe, Active and Progressive Rheumatoid Arthritis Treated with Certolizumab Pegol in Combination with Methotrexate
    Weinblatt, Michael
    Bingham, Clifton
    Burmester, Gerd
    Bykerk, V. P.
    Furst, Daniel E.
    Mariette, Xavier
    van der Heijde, Desiree
    Tatla, Daljit
    Arendt, Catherine
    Mountian, Irina
    VanLunen, Brenda
    Emery, Paul
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [48] Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
    Ruiz Garcia, Vicente
    Jobanputra, Paresh
    Burls, Amanda
    Cabello, Juan B.
    Vela Casasempere, Paloma
    Bort-Marti, Sylvia
    Kynaston-Pearson, Francis J. B.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (09):
  • [49] The clinical efficacy and safety of certolizumab pegol (CZP) in the treatment of rheumatoid arthritis: focus on long-term use, patient considerations and the impact on quality of life
    Fleischmann, Roy
    [J]. OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2009, 1 : 95 - 106
  • [50] LONG-TERM SAFETY OF 4-WEEKLY CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS: 5 YEAR RESULTS FROM AN OPEN LABEL EXTENSION STUDY
    Fleischmann, R.
    van Vollenhoven, R.
    Vencovsky, J.
    Alten, R.
    Davies, O.
    Stach, C.
    de Longueville, M.
    van Lunen, B.
    Choy, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 523 - 523
12345